Key Insights

Highlights

Success Rate

84% trial completion

Published Results

29 trials with published results (18%)

Research Maturity

77 completed trials (48% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 52/100

Termination Rate

9.4%

15 terminated out of 159 trials

Success Rate

83.7%

-2.8% vs benchmark

Late-Stage Pipeline

16%

26 trials in Phase 3/4

Results Transparency

38%

29 of 77 completed with results

Key Signals

29 with results84% success15 terminated

Data Visualizations

Phase Distribution

117Total
Not Applicable (60)
Early P 1 (1)
P 1 (9)
P 2 (21)
P 3 (11)
P 4 (15)

Trial Status

Completed77
Unknown32
Recruiting19
Terminated15
Withdrawn6
Active Not Recruiting5

Trial Success Rate

83.7%

Benchmark: 86.5%

Based on 77 completed trials

Clinical Trials (159)

Showing 20 of 20 trials
NCT06822738Phase 3RecruitingPrimary

A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma

NCT07235592RecruitingPrimary

PRESERFLO™ MicroShunt XI Observational PMCF Study With no Control Group

NCT05695027Phase 2Active Not RecruitingPrimary

Nicotinamide and Pyruvate for Open Angle Glaucoma: A Randomized Clinical Study

NCT04553523Not ApplicableRecruitingPrimary

Hydrus® Microstent New Enrollment Post-Approval Study

NCT06948773Not ApplicableActive Not RecruitingPrimary

A Study of the Helix Surgical System in Primary Open-Angle Glaucoma (POAG) and Cataract (HELIX)

NCT07619482Phase 1Not Yet Recruiting

Topical Insulin for Glaucoma (TING2)

NCT07617532Phase 3Not Yet Recruiting

Efficacy and Safety of DNN.31.19.026 for Ocular Hypertension or Primary Open-Angle Glaucoma

NCT07599241Not ApplicableRecruiting

Additive Efficacy of Physical Activity Program in Hypthyroidism Elder Females With Glaucoma and Fatty Liver Issues

NCT05902871Not ApplicableActive Not RecruitingPrimary

Direct Selective Laser Trabeculoplasty in Ethnic Chinese Population

NCT07390890RecruitingPrimary

DSLT for Reducing Medication in Glaucoma

NCT06682962Not ApplicableRecruiting

Transcorneal Electrical Stimulation for the Treatment of Visual Field Defects in Patients With Open-Angle Glaucoma

NCT07447011Not ApplicableRecruitingPrimary

Glaucoma Respsosne to Lifestyle Corrections in Sleep Apnea

NCT07358650Not ApplicableRecruitingPrimary

Clinical Study Evaluating the Safety and Performance of the MIST Device for Intraocular Pressure Reduction in Patients With Primary Open-Angle Glaucoma

NCT06144918Phase 2CompletedPrimary

Ph2 Placebo-Controlled Study for Safety & Ocular Efficacy of SBI-100 Ophthalmic Emulsion in Pts w/ Elevated Eye Pressure

NCT06991270Not ApplicableRecruitingPrimary

OMNI 3.1 Surgical System in Subjects With Primary Open-Angle Glaucoma

NCT04784234Not ApplicableTerminatedPrimary

Vision Preservation and Restoration Following a 6 Month Trial of GlaucoCetin

NCT00221897RecruitingPrimary

Diagnostic Innovations in Glaucoma Study

NCT04396002RecruitingPrimary

Glaucoma, Visual Field Loss, and Their Association With Life Space in Older Adults

NCT07076303RecruitingPrimary

A Prospective Study on the Efficacy of Direct Selective Laser Trabeculoplasty (DSLT) in Achieving >20% Intraocular Pressure (IOP) Reduction Without Medications at 6 Months in Naive, Untreated Glaucoma Patients

NCT07048886Phase 4Not Yet RecruitingPrimary

Rocklatan Adds Pressure Reduction After MIGS (Minimally Invasive Glaucoma Surgery)

Scroll to load more

Research Network

Activity Timeline